Research Programs
"I am extremely grateful for the support from Additional Ventures and MCHRI, which will allow us to carry out an exploratory high risk, high reward project that would have been very difficult to fund through traditional mechanisms. Our project will develop a mechanical device to drive favorable ventricular growth in patients with single ventricle congenital heart defects. Our hope is to ultimately identify novel functional cures for this complex and high-risk patient population."
Alison Marsden, PhD
Associate Professor, Pediatric (Cardiology); Bioengineering
22q11 Neuropsychiatry Research Program
The MCHRI Uytengsu-Hamilton 22q11 Neuropsychiatry Research Program aims to promote research to improve the neurocognitive outcomes and behavioral symptoms of 22q11.2 Deletion Syndrome with immediate (within 5 years) and long-term impact. Learn more.
Single Ventricle Disease Research Program
The MCHRI Additional Ventures Single Ventricle Innovation Research Program aims to promote truly innovative research to treat and functionally cure single ventricle heart disease. Learn more.
Stanford Medicine Children's Health Center for IBD & Celiac Disease Programs
The Stanford Medicine Children's Health Center for Inflammatory Bowel Disease (IBD) and Celiac Disease Research Programs support two funding opportunities to spark innovative research and development of new treatments to improve the lives of all children with IBD and celiac disease. Learn more.
Team Science and Translational Medicine Faculty Development Program
MCHRI is pleased to offer a new faculty development program focused on team science and translational medicine! The program will prioritize applications from instructors and assistant professors (UML/UTL/NTLR Faculty Lines) who propose innovative ideas and desire support in building robust teams to expedite development and establishment of focus areas or thematic “verticals.” Learn more.
Kidney Health Innovation Program
The Kidney Health Innovation Program supports two funding opportunities to accelerate transformative discoveries in pediatric kidney disease, glomerular disease, and the adolescent to adult transition for individuals with kidney disease.